If implemented, a Buy American mandate would disrupt existing supply chains, invite retaliatory actions from trading partners, and threaten timely access to medicines. In this current health crisis, such a mandate could even threaten our ability to adequately respond to the pandemic.

The media's latest obsession is attacking President Trump for "playing doctor" when he highlights doctors' reports of a successful treatment for COVID-19.

Bipartisan groups lay out principles for transparency and oversight of coronavirus stimulus spending.

The pandemic has demonstrated the need for more diversity in the pharmaceutical supply chain, not less.

This plan delivers the right amount of aid to the right people, and minimizes the eventual drain on taxpayer dollars.